Dechra Pharmaceuticals (LSE:DPH) Days Payable : 95.81 (As of Jun. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Dechra Pharmaceuticals Days Payable?

Dechra Pharmaceuticals's average Accounts Payable for the six months ended in Jun. 2023 was £91.4 Mil. Dechra Pharmaceuticals's Cost of Goods Sold for the six months ended in Jun. 2023 was £174.0 Mil. Hence, Dechra Pharmaceuticals's Days Payable for the six months ended in Jun. 2023 was 95.81.

The historical rank and industry rank for Dechra Pharmaceuticals's Days Payable or its related term are showing as below:

LSE:DPH' s Days Payable Range Over the Past 10 Years
Min: 48.56 Med: 51.23 Max: 83.01
Current: 83.01

During the past 13 years, Dechra Pharmaceuticals's highest Days Payable was 83.01. The lowest was 48.56. And the median was 51.23.

LSE:DPH's Days Payable is not ranked
in the Drug Manufacturers industry.
Industry Median: 86.3 vs LSE:DPH: 83.01

Dechra Pharmaceuticals's Days Payable increased from Jun. 2022 (86.85) to Jun. 2023 (95.81). It may suggest that Dechra Pharmaceuticals delayed paying its suppliers.

Dechra Pharmaceuticals Days Payable Historical Data

The historical data trend for Dechra Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dechra Pharmaceuticals Days Payable Chart

Dechra Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Payable

Get a 7-Day Free Trial

56.75

54.30

48.60

49.90

48.67

Dechra Pharmaceuticals Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Days Payable	Get a 7-Day Free Trial															100.31	85.79	86.85	104.89	95.81

Competitive Comparison of Dechra Pharmaceuticals's Days Payable

For the Drug Manufacturers - General subindustry, Dechra Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dechra Pharmaceuticals's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dechra Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Dechra Pharmaceuticals's Days Payable falls into.

Dechra Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Dechra Pharmaceuticals's Days Payable for the fiscal year that ended in Jun. 2023 is calculated as

	Days Payable (A: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jun. 2022 )	+	Accounts Payable (A: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2023 )	*	Days in Period
=	( (46	+	43.4)	/	2 )	/	335.2	*	365
=	44.7					/	335.2	*	365
=	48.67

Dechra Pharmaceuticals's Days Payable for the quarter that ended in Jun. 2023 is calculated as:

	Days Payable (Q: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2022 )	+	Accounts Payable (Q: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
=	( (139.3	+	43.4)	/	2 )	/	174	*	365 / 2
=	91.35					/	174	*	365 / 2
=	95.81

Dechra Pharmaceuticals Days Payable Related Terms

Thank you for viewing the detailed overview of Dechra Pharmaceuticals's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Dechra Pharmaceuticals (LSE:DPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dechra Pharmaceuticals PLC (LSE:DPH) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

DPHAY:USA DPHl:UK 1PK:Germany

Address

24 Cheshire Avenue, Cheshire Business Park, Lostock Gralam, Northwich, GBR, CW9 7UA

Website

https://www.dechra.com

Dechra Pharmaceuticals PLC is a major drug manufacturing company with a focus on veterinary pharmaceutical products. The company develops, manufactures, and markets its products exclusively for veterinarians globally. Dechra is structured along three segments, including being European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The vast majority of Dechra's revenue is generated in Europe, followed by the U.S. Dechra derives most of its revenue through its Companion Animal Product category, followed by food-producing animal products.

Dechra Pharmaceuticals (LSE:DPH) Headlines

No Headlines